Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Revolution Medicines (RVMD) Current Assets: 2019-2024

Historic Current Assets for Revolution Medicines (RVMD) over the last 6 years, with Dec 2024 value amounting to $2.3 billion.

  • Revolution Medicines' Current Assets rose 25.23% to $2.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 billion, marking a year-over-year increase of 25.23%. This contributed to the annual value of $2.3 billion for FY2024, which is 23.86% up from last year.
  • Per Revolution Medicines' latest filing, its Current Assets stood at $2.3 billion for FY2024, which was up 23.86% from $1.9 billion recorded in FY2023.
  • Over the past 5 years, Revolution Medicines' Current Assets peaked at $2.3 billion during FY2024, and registered a low of $454.1 million during FY2020.
  • Its 3-year average for Current Assets is $1.6 billion, with a median of $1.9 billion in 2023.
  • Data for Revolution Medicines' Current Assets shows a peak YoY skyrocketed of 238.95% (in 2020) over the last 5 years.
  • Yearly analysis of 5 years shows Revolution Medicines' Current Assets stood at $454.1 million in 2020, then climbed by 29.87% to $589.8 million in 2021, then increased by 11.94% to $660.2 million in 2022, then surged by 184.66% to $1.9 billion in 2023, then rose by 23.86% to $2.3 billion in 2024.